Регистрация на мероприятие была временно приостановлена.

Event Details

*This event will be conducted in English. 本次活動將以英文進行


Considering Taiwan's outstanding achievement on liver health management, Taiwan has the ability and opportunity to become the "Liver Health Management Center of Excellence in Asia." The forum will be providing suggestions and cooperation opportunity for Taiwan government and AmCham members in working together toward to that goal.

Agenda

08:30

40 mins

Registration and breakfast

09:10

10 mins

Opening remarks
• AIT Director Brent Christensen
• MOHW Minister Chen Shih-Chung (衛福部部長陳時中)

09:20

20 mins

Keynote speech: Promotion of Liver Health in the World: Opportunities and Challenges
• Vice President Chen Chien-Jen (副總統陳建仁)

09:40

20 mins

Taiwan’s achievements in liver health management
• Taiwan Association for the Study of the Liver President
Dr. Kao Jia-Horng (台灣肝臟研究學會理事長高嘉宏教授)

10:00

20 mins

Taiwan’s strategy for achieving World Health Organization (WHO) goals for liver disease
• MOHW National Hepatitis C Program Office Director
Dr. Pwu Raoh-Fang (C型肝炎旗艦計畫辦公室主任蒲若芳教授)

10:20

20 mins

WHO objectives for liver health management
• U.S. Center for Disease Analysis Managing Director
Dr. Homie Razavi

10:40

30 mins

Section 1: Hepatitis Panel discussion: How can Taiwan become a liver health Center of Excellence in Asia?
Moderator:• AbbVie Taiwan General Manager Ramanathan VelayuthamPanelists:• MOHW Deputy Minister Ho Chi-Kung (衛福部政務次長何啓功)• Taiwan Association for the Study of the Liver President Dr. Kao Jia-Horng (台灣肝臟研究學會理事長高嘉宏教授)• MOHW National Hepatitis C Program ...
Moderator:
• AbbVie Taiwan General Manager Ramanathan Velayutham

Panelists:
• MOHW Deputy Minister Ho Chi-Kung (衛福部政務次長何啓功)
• Taiwan Association for the Study of the Liver President Dr. Kao Jia-Horng (台灣肝臟研究學會理事長高嘉宏教授)
• MOHW National Hepatitis C Program Office Director Dr. Pwu Raoh-Fang (C型肝炎旗艦計畫辦公室主任蒲若芳)
• U.S. Center for Disease Analysis Managing Director Dr. Homie Razavi
Просмотреть больше

11:10

10 mins

Break

11:20

15 mins

Taiwan Hepatocellular Carcinoma (HCC) liver cancer R&D and treatment model
• China Medical University Hospital Vice President
Dr. Chiu Chang-Fang (中國醫藥大學附設醫院副院長邱昌芳教授)

11:35

30 mins

Section 2: HCC Liver Cancer Panel discussion: How can Taiwan become a liver health Center of Excellence in Asia?
Moderator:Merck Sharp & Dohme (MSD) Inc. Taiwan Managing Director Lai Li PangPanelists:• MOHW (TBC)• NHI Director General Dr. Lee Po-Chang(健保署署長李伯璋)• CMUH Vice President Dr. Chiu Chang-Fang(中國醫藥大學附設醫院副院長邱昌芳教授)• Bristol-Myers Squibb Inc. General Manag...
Moderator:
Merck Sharp & Dohme (MSD) Inc. Taiwan Managing Director Lai Li Pang

Panelists:
• MOHW (TBC)
• NHI Director General Dr. Lee Po-Chang(健保署署長李伯璋)
• CMUH Vice President Dr. Chiu Chang-Fang(中國醫藥大學附設醫院副院長邱昌芳教授)
• Bristol-Myers Squibb Inc. General Manager Sophia Lee
Просмотреть больше

12:05

10 mins

Panel summary report
• Gilead Sciences Inc. VP & GM for Asia Andrew Hexter

12:15

12:20

Closing remarks
• AmCham Taipei President William Foreman

Speakers

Documents

Tickets

Member & Guest

Breakfast Included

TW$ 1,400

Ticket Refund Policy

CANCELLATION DEADLINE: Oct 1st, 2018 (End of the Date)

To cancel without penalty, written cancellation must be received by AmCham 48 hours before the event, or else full Price of the event will be charged. Expense for any guests invited by an AmCham member will be billed to the member's account directly.

Меню